Virus 2021

About Us

Conference Series LLC Ltd invites all the participants from all over the world to attend Webinar on Virus on August 19,2021 which includes keynote presentations,  Poster presentations and Video presentations.

Virus 2021 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Virology, Emerging Viral Diseases and Vaccines. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Virology and Immunology.

All honourable authors are kindly encouraged to contribute to and help shape the webinar through submissions of their research abstracts, papers and e-posters in all areas of Virology and Immunology are cordially invited for presentation at the webinar.

Scientific Session

TRACK-1: Covid-19

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment.  Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The best way to prevent and slow down transmission is to be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using an alcohol based rub frequently and not touching your face.

TRACK-2: Virus Vaccines

Vaccination is the administration of a vaccine to help the immune system develop protection from a disease. Vaccines contain a microorganism in a weakened or killed state, or proteins or toxins from the organism. In stimulating the body's adaptive immunity, they help prevent sickness from an infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. Vaccines, such as the measles, mumps, rubella, chickenpox, and nasal spray flu vaccines contain live, but weakened viruses unless a person's immune system is weakened, it is unlikely that a vaccine will give the person the infection.

TRACK-3:Skin Infections

A skin infection occurs when parasites, fungi, or germs such as bacteria penetrate the skin and spread. When this happens, it can cause pain, swelling, other types of discomfort, and skin colour changes. A skin infection may be mild or serious. Skin infections are different from rashes.

TRACK-4:Sexually Transmitted Viral Infection

Sexually transmitted infections (STIs) are infections you can get by having sex with someone who has an infection. STIs can be caused by viruses or bacteria. STIs caused by viruses include hepatitis B, herpes, HIV, and the human papilloma virus (HPV). STIs caused by bacteria include chlamydia, gonorrhoea, and syphilis.

TRACK-5:Infectious Diseases

Infectious disease, also known as infectiology, is a medical specialty dealing with the diagnosis, control and treatment of infections. An infectious disease specialist's practice may consist largely of managing nosocomial (hospital-acquired) infections, or it may be out-patient based.Infectious diseases specialists typically serve as consultants to other physicians in cases of complex infections, and often manage patients with HIV/AIDS and other forms of Immunodeficiency.[1] Although many common infections are treated by physicians without formal expertise in infectious diseases, specialists may be consulted for cases where an infection is difficult to diagnose. They may also be asked to help determine the cause of a fever of unknown origin.

TRACK-7: Plant and Animal Virology

Veterinary virology is the study of viruses in non-human animals. It is an important branch of veterinary medicine. Plant viruses are viruses that affect plants. Like all other viruses, plant viruses are obligate intracellular parasites that do not have the molecular machinery to replicate without a host. Plant viruses can be pathogenic to higher plants.Most plant viruses are rod-shaped, with protein discs forming a tube surrounding the viral genome; isometric particles are another common structure. They rarely have an envelope.

TRACK-8:Viruses and Tumours

An infective agent that typically consists of a nucleic acid molecule in a protein coat, is too small to be seen by light microscopy, and is able to multiply only within the living cells of a host.Tumours are groups of abnormal cells that form lumps or growths. They can start in any one of the trillions of cells in our bodies. Tumours grow and behave differently, depending on whether they are cancerous (malignant), non-cancerous (benign) or precancerous

TRACK-8: Respiratory Viral Infections

Recently one of the most common viral infections are the respiratory tract infections. Respiratory tract infections are including with the infection of sinuses, throat, airways or lungs. The respiratory tract infections (RTI) are generally classified in tow subdivisions as Upper Respiratory tract infections (URTI) and Lower Respiratory tract infections (LRTI). The viruses which are associated with respiratory disorders these are adenovirus, Para influenza virus, respiratory syncytial virus, coronavirus, Coxsackie virus, human metapneumovirus.

TRACK-9:Structural and Molecular virology

Molecular virology refers to the study of viruses at the molecular level which involves the analysis of genes and gene products of viruses and study their interaction with host (human, plant or animal) cellular proteins. Structural Virology is the molecular mechanism used by viruses to invade host cells establish an infection and ensure that progeny virus particles are released into the environment, all while evading the host's immune defenes.Viruses are the smallest self -replicating organisms .Even though individually viruses are rather simple, as a group they are exceptionally diverse in both replication strategies and structures. Many viruses are important human pathogens.To study the life cycle of human virus, we use various technologies like X-ray crystallography, cryo-electron microscopy. We investigate macromolecular interactions associated with virus cell entry, genome replication, assembly, and maturation. Viruses are very simple enough that we can aspire to understand their biology at a molecular level. Our efforts are directed towards using structural information for the development of anti-viral drugs and vaccines.

TRACK-10: Insect Virus and Fungal Virology

As of late the molecular investigation on replication, host interaction in insect viruses have contributed greatly to molecular, cell and organismal microbiology. The straightforwardness with which many insect viruses are spread in cell cultures and animals, the high yields virus particles or virus encoded macromolecules, and the significance with which many insect viruses can be genetically operated for some experimental benefits provided by those pathogens .It deals with viruses that infect fungi are identified called Mycoviruses .These Mycoviruses generally have double-stranded RNA genomes andisometric particles, but around 30% of these viruses have positive sense and single-stranded RNA genomes, so they are true Mycoviruses ,that they must have an capability to be transmitted.

TRACK-11: Transmission of Viruses

Viral transmission is the process by which viruses spread between hosts. It includes spread to members of the same host species or spread to different species in the case of viruses that can cross species barriers. Transmissibility within human populations is a key determinant of epidemic potential. Many viruses that can infect humans are not capable of being transmitted by humans; most human transmissible viruses that emerge already have that capability at first human infection or acquire it relatively rapidly. Virus transmission to humans occurs via inhalation of aerosolized virus-contaminated rodent urine, saliva, and feces, rarely by rodent bites. Humans are usually considered as a dead-end host that does not transmit the virus further. For plant viruses, the pathways reviewed are vertical and horizontal transmission via pollen, and horizontal transmission by parasitic plants, natural root grafts, wind-mediated contact, chewing insects, and contaminated water or soil. For insect viruses, they are transmission by plants serving as passive “vectors,” arthropod vectors, and contamination of pollen and nectar.

TRACK-12: Veterinary virology

Viruses are smaller and simpler in construction than unicellular microorganisms, and they contain only one type of nucleic acid—either DNA or RNA—never both. As viruses have no ribosomes, mitochondria, or other organelles, they are completely dependent on their cellular hosts for energy production and protein synthesis. They replicate only within cells of the host that they infect. Animal virology developed largely from the need to control viral diseases in humans and their domesticated animals. Viruses, like other infectious agents, enter the animal body through one of its surfaces. They then spread either locally on one of the body surfaces or through lymphatic and blood vessels to produce systemic infection. Iridoviridae and African Swine Fever Virus, adenovirus, Papillomavirus and Polyomavirus, herpesvirus are some of the major viruses causing diseases in cattle. At least one major disease of each domestic animal species except sheep is caused by a herpesvirus, including such important diseases as infectious bovine rhinotracheitis, pseudorabies, and Marek's disease. However, there are several approaches to their prevention, control, and eradication. The most generally useful control measure is the use of vaccines.

TRACK-13: Viral Immunology and Immunopathology

Viral immunology is simply the study of immune responses to viruses. A prolonged tissue-damaging effect resulting from an immune reaction against viruses is considered immunopathology. Such situations most commonly involve persistent viruses, which are themselves often mildly cytodestructive in the absence of an immune reaction. Chronic tissue damage initiated by viruses can also result in development of an autoreactive and an occasionally oncogenic response.

Market Analysis

Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.

Global Virology Market

The global virology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.

Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.

Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.

Key Players in the Global Virology Market

The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.

Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer's, ebola, and HIV. The company also has many other candidates, which are currently under review.

Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.

Virology Market: Segmentation

Virology Market is segmented By Product Type into Diagnosing Test: DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests.

On the basis of diagnosis tests, hepatitis B, Hepatitis C, HIV, Human papillomavirus (HPV), and other tests (like influenza, Ebola, and dengue) are estimated to hold the largest market share globally during the forecast period. Viral Infection controlling Methods include Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, Immunomodulators), Interferon’s (Cytokines). Immunoprophylaxis therapy and antiviral drugs are the fastest growing market segments in the estimated forecast period.

Virology Market is segmented By Applications into Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections. STDs, Urinary tract infections, and respiratory tract infections are currently dominating as compared to the other application types in the global virology market. Virology Market is segmented By End Users into Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies.

Global Vaccines Market: Snapshot

The global vaccine market is driven by the rise in prevalence of infectious diseases, as it is considered to be the best way to prevent such diseases. In addition, emerging vaccines (Zika vaccines, dengue vaccines, cancer vaccines, and others), production of technologically advanced vaccines, advancements in vaccine delivery devices, and increase in immunization programs supplement the market growth.

According to the market research study in 2016, the global vaccines market was worth US$ 28.0 Bn and is projected to reach a value of US$ 48.0 Bn by the end of 2025. The market is predicted to register a promising 6.0% CAGR between 2017 and 2025.

Competitive Market Share

Some of the major players in global market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax. Industry players focus on new product development, mergers, and acquisition to strengthen their market position. Companies should face intense competition for development of novel products.